| Medco Makes Push Into Genetic Testing Medco is expanding its efforts to promote genetic tests that can signal how a person will react to a drug or to help decide what medicine is best. online.wsj.com |
Genomic Health: Possible Takeover Candidate? Jason Chew submits: Genomic Health (GHDX) is a pure-play oncology in-vitro diagnostics company with approved products and a pipeline to drive future growth. It fits in well with the growing importance of personalized medicine in the pharmaceutical industry. Personalized medicine is comprised of two parts- the drug, and the diagnostic, a combination sometimes referred to as Dx/Rx. Biomarker and companion diagnostic development have been most notable in the oncology field. The high clinical trial failure rate coupled with the advent of targeted therapies have certainly been drivers in this trend.According to a report by PriceWaterhouseCoopers (PWC), the diagnostics market is only 2% the size of the overall drug market. With encouragements from the FDA and current industry trends toward personalized medicine, this market is set for growth.Complete Story » seekingalpha.com |
Vote Sets Up Health-Plan Challenges Opponents of the Obama administration's health-care overhaul say Missouri voters' rejection of a key plank could re-energize the push in other states to challenge it. online.wsj.com |
New Facility Won't Use St. Vincent's Site North Shore-Long Island Jewish Health System will open an urgent care-center on West 20th Street, after the hospital failed to reach an agreement to house services in the bankrupt St. Vincent's Hospital. online.wsj.com |
Genzyme Corporation CEO Discusses Q3 2010 Earnings - Call Transcript Genzyme Corporation (GENZ)Q3 2010 Earnings CallOctober 20, 2010 11:00 am ETComplete Story » seekingalpha.com |